Cargando…
The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells
The ubiquitin-proteasome system is elementary for cellular protein degradation and gained rising attention as a new target for cancer therapy due to promising clinical trials with bortezomib, the first-in class proteasome inhibitor meanwhile approved for multiple myeloma and mantle cell lymphoma. Bo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538843/ https://www.ncbi.nlm.nih.gov/pubmed/31132676 http://dx.doi.org/10.1016/j.neo.2019.03.001 |
_version_ | 1783422252459491328 |
---|---|
author | Schmidt, Moritz Altdörfer, Vanessa Schnitte, Sarah Fuchs, Alexander Rolf Kropp, Korbinian Nepomuk Maurer, Stefanie Müller, Martin Rudolf Salih, Helmut Rainer Rittig, Susanne Malaika Grünebach, Frank Dörfel, Daniela |
author_facet | Schmidt, Moritz Altdörfer, Vanessa Schnitte, Sarah Fuchs, Alexander Rolf Kropp, Korbinian Nepomuk Maurer, Stefanie Müller, Martin Rudolf Salih, Helmut Rainer Rittig, Susanne Malaika Grünebach, Frank Dörfel, Daniela |
author_sort | Schmidt, Moritz |
collection | PubMed |
description | The ubiquitin-proteasome system is elementary for cellular protein degradation and gained rising attention as a new target for cancer therapy due to promising clinical trials with bortezomib, the first-in class proteasome inhibitor meanwhile approved for multiple myeloma and mantle cell lymphoma. Both bortezomib and next-generation proteasome inhibitors mediate their effects by targeting the 20S core particle of the 26S proteasome. The novel small molecule inhibitor b-AP15 affects upstream elements of the ubiquitin-proteasome cascade by suppressing the deubiquitinase activity of both proteasomal regulatory 19S subunits and showed promising anticancer activity in preclinical models. Nonetheless, effects of inhibitors on the ubiquitin-proteasome system are not exclusively restricted to malignant cells: alteration of natural killer cell-mediated immune responses had already been described for drugs targeting either 19S or 20S proteasomal subunits. Moreover, it has been shown that bortezomib impairs dendritic cell (DC) phenotype and function at different levels. In the present study, we comparatively analyzed effects of bortezomib and b-AP15 on monocyte-derived DCs. In line with previous results, bortezomib exposure impaired maturation, antigen uptake, migration, cytokine secretion and immunostimulation, whereas treatment with b-AP15 had no compromising effects on these DC features. Our findings warrant the further investigation of b-AP15 as an alternative to clinically approved proteasome inhibitors in the therapy of malignancies, especially in the context of combinatorial treatment with DC-based immunotherapies. |
format | Online Article Text |
id | pubmed-6538843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Neoplasia Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-65388432019-06-03 The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells Schmidt, Moritz Altdörfer, Vanessa Schnitte, Sarah Fuchs, Alexander Rolf Kropp, Korbinian Nepomuk Maurer, Stefanie Müller, Martin Rudolf Salih, Helmut Rainer Rittig, Susanne Malaika Grünebach, Frank Dörfel, Daniela Neoplasia Original article The ubiquitin-proteasome system is elementary for cellular protein degradation and gained rising attention as a new target for cancer therapy due to promising clinical trials with bortezomib, the first-in class proteasome inhibitor meanwhile approved for multiple myeloma and mantle cell lymphoma. Both bortezomib and next-generation proteasome inhibitors mediate their effects by targeting the 20S core particle of the 26S proteasome. The novel small molecule inhibitor b-AP15 affects upstream elements of the ubiquitin-proteasome cascade by suppressing the deubiquitinase activity of both proteasomal regulatory 19S subunits and showed promising anticancer activity in preclinical models. Nonetheless, effects of inhibitors on the ubiquitin-proteasome system are not exclusively restricted to malignant cells: alteration of natural killer cell-mediated immune responses had already been described for drugs targeting either 19S or 20S proteasomal subunits. Moreover, it has been shown that bortezomib impairs dendritic cell (DC) phenotype and function at different levels. In the present study, we comparatively analyzed effects of bortezomib and b-AP15 on monocyte-derived DCs. In line with previous results, bortezomib exposure impaired maturation, antigen uptake, migration, cytokine secretion and immunostimulation, whereas treatment with b-AP15 had no compromising effects on these DC features. Our findings warrant the further investigation of b-AP15 as an alternative to clinically approved proteasome inhibitors in the therapy of malignancies, especially in the context of combinatorial treatment with DC-based immunotherapies. Neoplasia Press 2019-05-25 /pmc/articles/PMC6538843/ /pubmed/31132676 http://dx.doi.org/10.1016/j.neo.2019.03.001 Text en © 2019 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original article Schmidt, Moritz Altdörfer, Vanessa Schnitte, Sarah Fuchs, Alexander Rolf Kropp, Korbinian Nepomuk Maurer, Stefanie Müller, Martin Rudolf Salih, Helmut Rainer Rittig, Susanne Malaika Grünebach, Frank Dörfel, Daniela The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
title | The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
title_full | The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
title_fullStr | The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
title_full_unstemmed | The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
title_short | The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells |
title_sort | deubiquitinase inhibitor b-ap15 and its effect on phenotype and function of monocyte-derived dendritic cells |
topic | Original article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538843/ https://www.ncbi.nlm.nih.gov/pubmed/31132676 http://dx.doi.org/10.1016/j.neo.2019.03.001 |
work_keys_str_mv | AT schmidtmoritz thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT altdorfervanessa thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT schnittesarah thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT fuchsalexanderrolf thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT kroppkorbiniannepomuk thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT maurerstefanie thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT mullermartinrudolf thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT salihhelmutrainer thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT rittigsusannemalaika thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT grunebachfrank thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT dorfeldaniela thedeubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT schmidtmoritz deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT altdorfervanessa deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT schnittesarah deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT fuchsalexanderrolf deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT kroppkorbiniannepomuk deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT maurerstefanie deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT mullermartinrudolf deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT salihhelmutrainer deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT rittigsusannemalaika deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT grunebachfrank deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells AT dorfeldaniela deubiquitinaseinhibitorbap15anditseffectonphenotypeandfunctionofmonocytederiveddendriticcells |